MK0476 [montelukast] phase II/III placebo controlled double blind study.
Phase of Trial: Phase III
Latest Information Update: 15 Jul 2014
At a glance
- Drugs Montelukast (Primary)
- Indications Acute asthma
- Focus Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 01 Aug 2012 Results published in the Journal of Asthma.
- 01 Aug 2012 Patient numbers changed from 225 to 242 as stated in the published article
- 24 Mar 2009 Trial phase changed from II/III to III as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History